US Stock MarketDetailed Quotes

ALNY Alnylam Pharmaceuticals

Watchlist
  • 143.310
  • -0.400-0.28%
Close Apr 26 16:00 ET
  • 146.710
  • +3.400+2.37%
Post 19:42 ET
18.12BMarket Cap-40713P/E (TTM)

Alnylam Pharmaceuticals Key Stats

Alnylam Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings Estimates

May 2, 2024

Revenue(YoY)

426.86M

+33.69%
EPS(YoY)

-1.17

+16.74%

Buy

Apr 27, 2024

Alnylam Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 22 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 462.652M--
May 2, 20242024/Q1-- / 426.861M--
Feb 15, 20242023/Q4439.718M / 442.296M--
Nov 2, 20232023/Q3750.530M / 394.549M--
Aug 3, 20232023/Q2318.754M / 350.571M--
May 4, 20232023/Q1319.290M / 312.535M--
Feb 23, 20232022/Q4335.035M / 312.450M--
Oct 27, 20222022/Q3264.306M / 291.658M--
Jul 28, 20222022/Q2224.818M / 256.058M--
Apr 28, 20222022/Q1213.259M / 242.823M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 462.652M--
May 2, 20242024/Q1-- / 426.861M--
Feb 15, 20242023/Q4439.718M / 442.296M--
Nov 2, 20232023/Q3750.530M / 394.549M--
Aug 3, 20232023/Q2318.754M / 350.571M--
May 4, 20232023/Q1319.290M / 312.535M--
Feb 23, 20232022/Q4335.035M / 312.450M--
Oct 27, 20222022/Q3264.306M / 291.658M--
Jul 28, 20222022/Q2224.818M / 256.058M--
Apr 28, 20222022/Q1213.259M / 242.823M--

Unlock Free Earnings Estimates

Alnylam Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 27, 2024

Buy

  • Buy

    56.52%
  • Hold

    43.48%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg